Haven't been to the university since that last study I got. )c: Too busy with work, new system is being implimented and tested, and I have to write the dang training manual.
I think you're right on inhibitting binding. Test that would normally be bound is allowed to be free is how it works. It's dose dependent with no toxicity warnings that I know of too, so the more the merrier it seems.
Max LMG is the replacement for ErgoMax LMG. The new one is an antiprogestin which seems to be doing some people some good. Might also be a handy add-in for AAS cycles including trenbelone and nandrolone too.
The ALRI product with the claimed SARM in it is Ultra H.O.T. If you look on the anabolicminds boards there were some studies posted that confirmed to some extent the different androgen receptor activity in different tissues. They use an analog of ATD, the same active in Designer Supplements Rebound XT. If the claims are true, 80-90% reduction in the hypothalumus with only 10% in muscle, this would indeed be a wild product. Nothing will ever totally blind the body to hormonal changes I think, there are too many feedback loops to let it know something's out of whack. If true though this one could limit the supression of natural test production on cycle fairly well, allowing more effective cycles wth easier PCTs, and perhaps longer cycles too of substances like test cyp.
So far as I know though, the higher binding affinity of the ATD analog to the androgen receptors in the hypothalumus is only effective when it comes to testosterone. Blocking the activity, and the suppression it leads to, of other substances is still up in the air.